Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8567705 | 0.81 | SMN1; SMN2 (0.47) | SMN1; SMN2MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL29390571 | 0.80 | SMN1; SMN2 (0.53) | SMN1; SMN2MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL78000 | 0.80 | SMN1; SMN2 (0.53) | SMN1; SMN2MEN1KMT2ARAB9ANPC1 | |
| Water SCHEMBL7798110 | 0.78 | SMN1; SMN2 (0.51) | SMN1; SMN2MEN1KMT2ARAB9ANPC1 | |
| Hydrochloric Acid SCHEMBL7500894 | 0.78 | SMN1; SMN2 (0.51) | SMN1; SMN2MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL6447477 | 0.75 | RAB9A (0.56) | SMN1; SMN2RAB9ANPC1POLBCYP1A2 | |
| SCHEMBL19512770 | 0.75 | ALDH1A1 (0.40) | SMN1; SMN2MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL18415567 | 0.74 | SMN1; SMN2 (0.75) | SMN1; SMN2MEN1KMT2ARAB9ANPC1 | |
| Methyl Alcohol SCHEMBL3396777 | 0.74 | ALDH1A1 (0.53) | SMN1; SMN2MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL1258953 | 0.73 | RAB9A (0.54) | SMN1; SMN2RAB9ANPC1POLBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10669242-B2 | Clostridium difficile toxin inhibitors | Venenum Biodesign, LLC (US) | 2020-06-02 | — | — | US | disclosed |
| US-20190194147-A1 | Novel Clostridium Difficile Toxin Inhibitors | Venenum Biodesign, LLC (US) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194147-A1 | Novel Clostridium Difficile Toxin Inhibitors | GABRA5, GABRA1, GABRA4 | SMN1; SMN2 4568/4885MEN1 4531/4885KMT2A 2401/4885 |
| US-10669242-B2 | Clostridium difficile toxin inhibitors | GABRA5, GABRA1, GABBR2 | SMN1; SMN2 4410/4885MEN1 4285/4885KMT2A 2561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.